Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Lisa Holland(West Virginia University), Guanglin Cui(University of Oxford), Belinda Goodenough(UNSW Sydney), William Stevens(University of Oxford), John J. Welch(University of Cambridge), Karl Wallendszus, Janet Wittes(Statistics Collaborative), Charles Crichton(University of Oxford), Charlie Harper, Peter Sandercock(University College London), Hizni Salih(University of Oxford), Mohamed A. Zayed(Cairo University), Samuel R. Chamberlain(University of Cambridge), Heather Halls, Andrea Cradduck-Bamford(University of Oxford), Raph Goldacre(Open Data Institute), Adilia Warris(University of Exeter), Jonathan D. Wiles(University of Oxford), David L. DeMets(University of Wisconsin–Madison), Scott J. Cameron(Cleveland Clinic), Sarah Howard(University of Oxford), Wojciech Brudlo(University of Oxford), Jill Barton(University Hospitals Birmingham NHS Foundation Trust), Alexander H. King(Mayo Clinic in Arizona), David G. Lalloo(Liverpool School of Tropical Medicine), Lucy Fletcher(University of Oxford), Christina Reith(University of Oxford), Ann R. Kennedy(University of Pennsylvania), Ahmet Başoğlu(University of Oxford), Katherine Davies(University of Oxford), R. Wels(University of Oxford), Robert Fowler(Sunnybrook Health Science Centre), David W. Murray(Nuffield Orthopaedic Centre), Miles A. Nunn(UK Centre for Ecology & Hydrology), Mohammed Munavvar(Lancashire Teaching Hospitals NHS Foundation Trust), É. Denis(University of Oxford), Hannah Freeman(Dana-Farber Cancer Institute), K. Taylor(University of Oxford), F. I. KNIGHT(University of Oxford), Anne Whitehouse(University of Oxford), GRANT P. BAGLEY(University of Oxford), M Lay(University of Oxford), C Wood(University of Oxford), Barbara Farrell(University of Oxford), Janet Darbyshire(MRC Clinical Trials Unit at UCL)
Cited by 11
Related Papers
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Interpretation of the evidence for the efficacy and safety of statin therapy
|The Lancet|2016|1.8k